A new study released Monday said Merck's widely used antiviral Covid pill can cause mutations in the virus that occasionally ...

Merck made a formal request for Emergency Use Authorization from the FDA Monday for its COVID-19 pill treatment, known as molnupiravir. Merck (MRK) said Monday it has submitted a formal ...

An FDA advisory committee voted by 13 to 10 to recommend emergency-use authorisation for Merck & Co and Ridgeback's oral antiviral molnupiravir for mild-to-moderate COVID-19, saying it would be ...

While Merck and its partner Ridgeback Biotherapeutics were the first to submit their COVID-19 pill to the FDA, rival drugmaker Pfizer is close behind with its own pill under review.

The first-ever COVID-19 pill could be available before the end of the year. This week, Merck and Ridgeback Biotherapeutics asked the Food and Drug Administration (FDA) to authorize their antiviral ...

WASHINGTON--Drugmaker Merck asked U.S. regulators Monday ... first pill shown to treat the illness. All other FDA-backed treatments against COVID-19 require an IV or injection.

The FDA authorized Merck’s drug for adults with a positive COVID-19 test, early symptoms and who face the highest risks of hospitalization, including older people and those with conditions like ...

Merck & Co is on the brink of plugging a gap in the coronavirus treatment armamentarium after its oral drug molnupiravir cut deaths and hospitalisations in mild or moderate COVID-19 in a phase 3 ...

The Food and Drug Administration approved the latest Covid vaccines yesterday ... Columbia that bears the Vagelos family name. A former Merck CEO, Roy Vagelos is the child of Greek immigrants ...

Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...

An experimental COVID-19 treatment pill called Molnupiravir ... pill said to be effective against the virus. The drug manufacturer- Merck’s clinical trial on the pill Molnupiravir has been ...